Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

Immune Checkpoint Inhibitors & Mortality

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

Patients with AEs had higher risks of hospitalizations, emergency room visits, and higher health care costs, driven by inpatient stays, than patients without AEs. The adjusted risk of mortality was similar between the two cohorts.
George et al. 2021b The Oncologist 26: e1205-e1215

…

References (Sources)

The Impact of Adverse Events on Health Care Resource Utilization, Costs, and Mortality Among Patients Treated with Immune Checkpoint Inhibitors
George et al. 2021b The Oncologist 26: e1205-e1215
Thirty-day mortality rates after immunotherapy initiation
Sütcüoğlu et al. 2021 Immunotherapy 13: 1419-1426

AI Chat

7/1/2026

Chat with our artificial intelligence:

Start chat!

Immune Checkpoint Inhibitors & Mortality

Welcome to meRfi Microbiome!

Navigation

Contents

References (Sources)

AI Chat